B・SYNC ON Expert - Dr. Firat Yerlikaya
Manufacturing and Formulation

Dr. Fırat Yerlikaya

I'm passionate about the development of formulations, manufacturing processes and new technologies.

About Firat

Dr Fırat Yerlikaya founded Elixir Pharmaceutical Research and Development Corporation in Ankara, Turkey where he has been working as the Managing Director and as an Executive Board Member since 2015.

He formed the company following the completion of his Master's and Doctorate Degrees in Pharmaceutical Technology and following his tenure in Washington DC, where he was invited to the US FDA as an ORISE fellow.

Fırat continues his scientific studies with the development of complex pharmaceutical formulations and processes using quality-by-design and chemometric models.

At B・SYNC ON parent company, Galventa, Fırat is responsible for supporting the development of formulations, manufacturing processes, scale-up and technology transfer studies, as well as providing analytical methodology and insights.

Outside of his academic studies and work, Fırat is a passionate sailor, and enjoys sailing in the seas where Galenos used to live. He also enjoys fine whisky and good food with his family and friends.

Fırat is a proud father of two young sons. He is also proud of his success in establishing Elixir, which is considered to be one of the most successful pharmaceutical development laboratories in Europe.

Publications

A Novel Bedtime Pulsatile-Release Caffeine Formula Ameliorates Sleep Inertia Symptoms Upon Waking

Formation of Quantum Water in Nanoparticulate Systems

Development of Paclitaxel and Flurbiprofen Co-Loaded PLGA Nanoparticles: Understanding Critical Formulation and Process Parameters Using Plackett–Burman Design

Development and In Vitro Evaluation of Doxorubicin and Celecoxib Co-Loaded Bone Targeted Nanoparticles

Development and Validation of a Stability-Indicating Ultra-Performance Liquid Chromatography (UPLC) Method for Doxycycline Hyclate: An Optimization of the Analytical Methodology for a Medical Countermeasure (MCM) Drug

A Comparative Evaluation of Polystyrene Divinylbenzene Copolymer HPLC Columns on the Chromatographic Performance of the Compendial Method for Doxycycline Hyclate Capsules: Implications for Method Implementation of a Medical Countermeasure Medication

A Glance on the History of Pharmaceutical Quality by Design

A Small Variation in Average Particle Size of PLGA Nanoparticles Prepared by Nanoprecipitation Leads to Considerable Change in Nanoparticles’ Characteristics and Efficacy of Intracellular Delivery

Formulation and Process Factors Influencing Product Quality and In Vitro Performance of Ophthalmic Ointments

Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

An Aquaporin 4 Antisense Oligonucleotide Loaded, Brain Targeted Nanoparticulate System Design

Comparative Evaluation of In Vitro Parameters of Tamoxifen Citrate Loaded Poly(lactide-co-glycolide),
Poly(epsilon-caprolactone) and Chitosan Nanoparticles

The Influence of Technological Parameters on the Physicochemical Properties of Blank PLGA Nanoparticles

LC-UV Determination of Melatonin from Chitosan Nanoparticles

B・SYNC ON expert - Dr. Dario Dornbierer - Psychopharmacologist

MEET THE EXPERTS

Meet the team of scientists and innovators, that are working every day to help you improve your sleep and waking up.
MEET THE EXPERTS